opnMe.com - Thank you for your continued support!
21 December 2022
opnMe.com marked its 5th birthday in November 2022. Born out of the idea to find a new way to share with the scientific community the groundbreaking research taking place at Boehringer Ingelheim, as well as the expertise of our scientists, opnMe’s adoption has surpassed even our most optimistic expectations. We are very thankful for your ongoing engagement and take this opportunity to share with you the following successes:
- Scientists from 70 countries around the globe have interacted with opnMe.com so far.
- Our molecules and the opnMe platform have been cited >90 times in scientific publications.
- Our Molecules to order program now features 75 highly specific and extensively characterized modulators, inhibitors, and degraders; with negative controls available for most of them. We continue to release new molecules on a regular basis.
- We hope to contribute to better experimental design by proactively encouraging orders of negative controls, likewise synthesized and shipped free of charge. Since we have started to encourage the use of negative controls with each molecule order, the orders without negative control doubled while the orders with negative controls increased by factor six.
- We have launched 38 calls for proposals as part of our collaborative research initiatives (Molecules for collaboration and opn2EXPERTS) that have resulted into more than 60 research collaborations so far.
- As part of our More Green IU Sustainability program, we have branched outside the confines of traditional biomedical research with our first opn2EXPERTS call centered around reducing reducing water and energy consumption as part of biologics downstream processes.
All of this would not have been possible without you and we owe you a big “thank you” for embracing our innovative #openscience approach.
As a small token of appreciation, we are making available for download six new opnMe backgrounds that you can use for your video conferences or desktop.
We wish you all the best for the festive season and look forward to you being part of our journey in 2023.
Your opnMe team.
Please note that our offices will be closed from Dec 24 until Jan 2. All orders and other inquiries during this period will be addressed upon our return to office on Jan 3, 2023.
About opnMe:
opnMe.com, the new open innovation portal of Boehringer Ingelheim, aims to accelerate research initiatives to enable new insights of disease biology in areas of high unmet medical need by sharing well-characterized molecules and offer collaborations for science. In the spirit of collaboration, our molecules are provided to the scientific community to help unlock and fulfill their full potential. These molecules are either freely available as “Molecules to Order” or applied via scientific research submissions as “Molecules for Collaboration”. As part of our third pillar, our “opn2EXPERTS” program, we also enlist scientific advice on key biologic issues to fuel further drug discovery and deliver novel solutions that benefit unmet patient needs.